OBJECTIVE: The association between codon 72 polymorphism of the tumour protein p53 (TP53) gene -which results in a missense mutation of arginine (R) to proline (P) -and susceptibility to hepatocellular carcinoma (HCC) is controversial. A metaanalysis was performed in order to define this relationship more precisely. METHODS: Published studies of TP53 codon 72 polymorphism and the risk of HCC were identified. Data were extracted, and summary odds ratios (OR) and 95% confidence intervals (95% CI) were calculated. Pooled ORs were determined for an additive model (
Introduction
Hepatocellular carcinoma (HCC) accounts for 85 -90% of primary liver cancers, which are the fifth most common cancers worldwide. 1 The distribution of HCC varies among geographic regions and ethnic groups. 2 The incidence of this disease is increasing in developed countries in spite of considerable diagnostic and therapeutic progress. 3 The development of HCC is a complex, gradual, multistep process involving many factors. Epidemiological studies have identified major risk factors for HCC, including infection with hepatitis B or C virus (HBV or HCV), 4 exposure to certain chemicals (such as aflatoxin B 1 ) 5 or high alcohol intake. 6 Not all individuals who are exposed to risk factors develop cancer, 7 suggesting that genetic factors are involved in susceptibility.
Several potential HCC susceptibility genes have been identified, 8 Tumour protein p53 is a tumour suppressor that plays an important role in cell cycle regulation and the maintenance of genome integrity. 9 TP53 mediates the cellular response to DNA damage via effects on gene transcription, DNA synthesis and repair, genomic plasticity and apoptosis. 10 Mutation of TP53 can result in uncontrolled cell proliferation and is associated with an increased risk of several cancers, including HCC. 11 Several studies have investigated the association of TP53 polymorphisms with the risk of cancer. 12 -14 The most studied polymorphism in the TP53 gene is a G>C replacement in exon 4, at codon 72. 15 This results in a mis-sense mutation of arginine (R) to proline (P) 16 and the production of a protein with different biological and biochemical characteristics. There are three possible distinct TP53 genotypes: homozygous for arginine (R/R); homozygous for proline (P/P); and heterozygous (R/P). Studies regarding the possible association of this polymorphism with HCC have shown inconclusive results, and most have included only small numbers of cases and controls. This meta-analysis was conducted in order to determine the effects of this polymorphism on the risk of HCC.
Materials and methods

IDENTIFICATION OF STUDIES
A literature search was conducted in order to identify studies that examined the association of the TP53 codon 72 polymorphism with HCC. The search included all papers published up to July 2011, in any language, that were included in PubMed or Chinese National Knowledge Infrastructure (CNKI) databases. The key words and subject terms used included: 'TP53'; 'p53'; 'codon 72'; 'hepatocellular carcinoma'; 'tumor'; 'cancer'; and 'polymorphism'.
Potentially relevant publications were evaluated by checking their titles and abstracts, and the most relevant (according to the selection criteria described below) were obtained for detailed examination. The reference lists of the selected papers were screened for other potential articles that may have been missed in the initial search. The analysis included only published studies with full text articles. When the same patient population was included in more than one publication, only the most recent or most complete study (based on publication date and the number of patients) was included in the metaanalysis.
SELECTION CRITERIA
The following criteria were used for selection of publications for the meta-analysis: (i) evaluation of the TP53 codon 72 polymorphism with risk of HCC; (ii) casecontrol studies; (iii) sufficient published data for estimating an odds ratio (OR) with 95% confidence intervals (CI); and (iv) genotype distribution of the control population was in Hardy-Weinberg equilibrium. All papers were reviewed for further analysis in accordance with these criteria. There was no minimum number of patients per study for inclusion in the meta-analysis.
DATA EXTRACTION
Data were extracted from eligible publications independently by two investigators (C.D., H.Y.), with any disagreement resolved by discussion between them. In the event that these two investigators could not reach a consensus, another author (H.Q.) was consulted to resolve the dispute, with a final decision reached by majority vote.
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The following data were collected from each study: first author's name; publication date; ethnicity of study population; genotype frequency; and experimental design (population-based or hospital-based control population). Ethnicities were categorized as Caucasian, Asian or African, and subject source was stratified as population-or hospital-based.
STATISTICAL ANALYSES
Crude ORs with 95% CIs were used to assess the strength of the association between the TP53 codon 72 polymorphism and risk of HCC. Pooled ORs were generated for an additive model (R/R versus P/P), a dominant model ([R/R + R/P] versus P/P) and a recessive model (R/R versus [R/P + P/P]). Stratification analysis was performed by ethnicity, hepatitis virus infection status and study design (hospital-or population-based).
The χ 2 -test was used to determine whether genotype distribution in controls was in Hardy-Weinberg equilibrium, with a P-value ≤ 0.05 indicating a departure from equilibrium. The Q-test and I 2 statistic were used to investigate the degree of heterogeneity between the studies. 17 If the Qtest resulted in a P-value > 0.05 (indicating a lack of heterogeneity) the pooled OR estimate of each study was calculated by the fixed-effects model (the Mantel-Haenszel method). 18 If the Q-test resulted in a P-value < 0.05, the random-effects model (the DerSimonian and Laird method) was used. 19 Sensitivity analysis was performed in order to assess the stability of the results. A single study involved in the meta-analysis was deleted each time to reflect the influence of the individual data set on pooled ORs. Potential publication bias was assessed by visual inspection of Begg's funnel plots, 20 where the standard error of log OR of each study was plotted against its log OR. An asymmetrical plot indicated possible publication bias. The symmetry of the funnel plot was evaluated further by Egger's linear regression test, with a P-value < 0.05 considered to be indicative of significant publication bias. 21 Statistical analyses were performed using Stata ® version 10.1 (StataCorp LP, College Station, TX, US).
Results
The literature search identified 11 studies, seven of which met the inclusion criteria. 12 -14,22 -25 Of the four studies excluded from the analysis, two had duplicated data 26, 27 and two included control populations where the genotype distribution deviated from Hardy-Weinberg equilibrium. 28, 29 The final meta-analysis included 1511 cases and 2165 controls. The main characteristics of the studies included in the analysis are shown in Table 1 . Almost all of the cases were pathologically confirmed.
Meta-analysis of the overall data found a significantly decreased risk of HCC for the dominant model ( Fig. 1, Table 2 ) but not the additive model or recessive model ( Table 2) .
There was no significant association between polymorphism and the risk of HCC when data were stratified according to HBV/HCV infection status. There was a significantly decreased risk for all three models (additive, dominant and recessive) in hospital-based studies but not in populationbased studies ( Table 2) . When data were stratified by ethnicity, Asians were found to have a significantly decreased risk in the dominant model (Table 2) .
Sensitivity analyses revealed no material alteration in pooled ORs when studies were individually deleted from the meta-analysis (data not shown). There was no obvious asymmetry in the shape of the Begg's funnel plot (Fig. 2) . Egger's test found no evidence of publication bias. 
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Discussion
Studies have found conflicting results regarding the association between TP53 codon 72 polymorphism and the risk of HCC, possibly influenced by the relatively small sample size and different genetic backgrounds of the study populations. Metaanalysis is a powerful tool for resolving inconsistent findings with a relatively large number of subjects. This meta-analysis investigated the association between TP53 codon 72 polymorphism and HCC risk in 1511 cases and 2165 control subjects.
The TP53 codon 72 polymorphism is located in the proline-rich domain of p53, which is necessary for the protein fully to induce apoptosis. 30 The underlying mechanisms by which the TP53 polymorphisms influence cancer risk are not fully understood, but it has been shown that the R-72 variant induces apoptosis more effectively than the P-72 variant. 30 The present meta-analysis found that individuals with the R/R or R/P genotype had a significantly smaller cancer risk than P/P carriers.
The finding that Asians, but not Caucasians, had a significantly decreased risk of HCC in the dominant model may be due to the different genetic backgrounds of these two ethnic groups. Cancer is a *Statistically significant risk. TP53 codon 72 polymorphism and HCC complicated disease, and it is common for the same polymorphism to play different roles in cancer susceptibility between different ethnic populations. 31 The present meta-analysis found a significantly decreased HCC risk for all models in hospital-based studies but not in population-based studies. This may be due to the inherent bias in hospital-based studies, since the control populations in these studies may represent a sample of an ill-defined reference population. The control groups may not be representative of the general population, particularly when the genotypes under investigation are associated with disease conditions present in the hospitalbased controls. It is important, therefore, to use representative population-based control populations in order to reduce bias in genetic association studies.
It is widely accepted that chronic hepatitis virus infection is a risk factor for HCC. 32 The present analysis found no significant association between polymorphism and HCC risk in HBV-or HCV-positive individuals. There were only two studies that investigated the association; thus, more studies are needed to clarify the validity of the association.
There were some limitations to the present meta-analysis. First, only published studies were included and it is possible that relevant works were excluded -such as conference reports and unpublished studies with negative findings -resulting in publication bias. Secondly, results were based on unadjusted estimates (i.e. not adjusted for age, environmental factors or lifestyle), and individual data would allow for such adjustment and a more precise analysis. Finally, the number of Caucasians included in the subgroup analysis was small, and there was insufficient statistical power to explore the association of the polymorphism with HCC susceptibility in this subgroup. The meta-analysis had the advantage of including a substantial number of cases and controls, which significantly increased the statistical power of the analysis. In addition, no publication bias was detected, indicating that the pooled results were reliable.
In conclusion, this meta-analysis indicated that TP53 codon 72 polymorphism may be a risk factor for the development of
HCC.
Large sample studies using standardized unbiased genotyping methods and well-matched controls are required to investigate this association further.
